Pfizer to provide Covid-19 vaccines for 72 million people in Japan
Tokyo: The Japanese government has signed agreements with US pharmaceutical company Pfizer Inc. to receive the drugmaker's Covid-19 vaccine doses enough for a total of 72 million people within this year, the Health Ministry said.
The additional supply added to the country's agreement last year with the drugmaker to acquire doses for 60 million people, which accounted for roughly half the country's population of 126 million, reports Xinhua news agency.
According to the Yomiuri Shimbun newspaper, the government hopes majority of the adults will be vaccinated by July, when the Olympic Games are slated to open.
The country aims to begin inoculating the general public against Covid-19 from May after vaccinating medical workers and the most vulnerable, according to local media reports.
Prime Minister Yoshihide Suga said on Wednesday that Japan aims to start the vaccinations "as soon as possible," as the country is struggling to curb the spread of the virus amid a resurgence and the mounting pressure on the medical system.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.